ARCHIVES

FDA Proposal On Dissemination of Off-Label Drug Information Doesn’t Go Far Enough, Cancer Groups Say

This article is from The Cancer Letter archive.

Vol. 22 No. 04 | January 26, 1996

Download PDF Visit The Full Archive

Related Articles

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

October 3, 2014

NCI-Approved Clinical Trials

May 28, 2004

Also Kevin Cullen named director, Univ. of Maryland Greenebaum Cancer Center.

November 28, 2003

Virus Cancer Program Report On Scientific Activities

August 1, 1975

In Brief: McDonnell Foundation Selects Five For Awards; James Benson Is Named Interim FDA Head

November 24, 1989

NCI Must Limit Grant Payments for Now, Until Congress Approves FY03 Budget

December 6, 2002